Cite
The inhibition of BRAF activity sensitizes chemoresistant human ovarian cancer cells to paclitaxel-induced cytotoxicity and tumor growth inhibition
MLA
Ling, Zhao, et al. “The Inhibition of BRAF Activity Sensitizes Chemoresistant Human Ovarian Cancer Cells to Paclitaxel-Induced Cytotoxicity and Tumor Growth Inhibition.” American Journal of Translational Research, vol. 12, no. 12, Sept. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........f7ac4bc22e6b8e8b3024355c933eba8c&authtype=sso&custid=ns315887.
APA
Ling, Z., Linjuan, H., Jing, Z., Jiaming, F., Fang, H., Xia, Z., Hao, W., Qing, L., Deyao, S., Na, N., William, W., Mikhail, P., Kai, F., Andrew B, T., Connie, C., Russell R, R., Rex C, H., Hue H, L., Le, S., … Tong-Chuan, H. (2020). The inhibition of BRAF activity sensitizes chemoresistant human ovarian cancer cells to paclitaxel-induced cytotoxicity and tumor growth inhibition. American Journal of Translational Research, 12(12).
Chicago
Ling, Zhao, Huang Linjuan, Zhang Jing, Fan Jiaming, He Fang, Zhao Xia, Wang Hao, et al. 2020. “The Inhibition of BRAF Activity Sensitizes Chemoresistant Human Ovarian Cancer Cells to Paclitaxel-Induced Cytotoxicity and Tumor Growth Inhibition.” American Journal of Translational Research 12 (12). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........f7ac4bc22e6b8e8b3024355c933eba8c&authtype=sso&custid=ns315887.